Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Brazil.
FEBS Open Bio. 2023 May;13(5):912-925. doi: 10.1002/2211-5463.13595. Epub 2023 Mar 25.
Imidazole is largely employed in recombinant protein purification, including GH1 β-glucosidases, but its effect on the enzyme activity is rarely taken into consideration. Computational docking suggested that imidazole interacts with residues forming the active site of the GH1 β-glucosidase from Spodoptera frugiperda (Sfβgly). We confirmed this interaction by showing that imidazole reduces the activity of Sfβgly, which does not result from enzyme covalent modification or promotion of transglycosylation reactions. Instead, this inhibition occurs through a partial competitive mechanism. Imidazole binds to the Sfβgly active site, reducing the substrate affinity by about threefold, whereas the rate constant of product formation remains unchanged. The binding of imidazole within the active site was further confirmed by enzyme kinetic experiments in which imidazole and cellobiose competed to inhibit the hydrolysis of p-nitrophenyl β-glucoside. Finally, imidazole interaction in the active site was also demonstrated by showing that it hinders access of carbodiimide to the Sfβgly catalytic residues, protecting them from chemical inactivation. In conclusion, imidazole binds in the Sfβgly active site, generating a partial competitive inhibition. Considering that GH1 β-glucosidases share conserved active sites, this inhibition phenomenon is probably widespread among these enzymes, and this should be taken into account when considering the characterization of their recombinant forms.
咪唑广泛应用于重组蛋白纯化,包括 GH1β-葡萄糖苷酶,但很少考虑其对酶活性的影响。计算对接表明,咪唑与形成 Spodoptera frugiperda( Sfβgly) GH1β-葡萄糖苷酶活性位点的残基相互作用。我们通过证明咪唑降低 Sfβgly 的活性来证实这种相互作用,这不是由于酶的共价修饰或促进转糖苷反应所致。相反,这种抑制作用是通过部分竞争性机制发生的。咪唑结合到 Sfβgly 的活性部位,使底物亲和力降低约三倍,而产物形成的速率常数保持不变。通过在活性部位进行酶动力学实验进一步证实了咪唑的结合,其中咪唑和纤维二糖竞争抑制对硝基苯-β-葡萄糖苷的水解。最后,通过显示它阻碍了碳二亚胺与 Sfβgly 催化残基的结合,从而保护它们免受化学失活,证明了咪唑在活性部位的相互作用。总之,咪唑结合在 Sfβgly 的活性部位,产生部分竞争性抑制。考虑到 GH1β-葡萄糖苷酶具有保守的活性部位,这种抑制现象可能在这些酶中广泛存在,在考虑其重组形式的表征时应考虑到这一点。